Yutaka Niihara - 03 Nov 2022 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Issuer symbol
EMMA
Transactions as of
03 Nov 2022
Net transactions value
+$21,225
Form type
4
Filing time
01 Dec 2022, 12:35:44 UTC
Previous filing
03 Nov 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $1,125 +2,500 +0.02% $0.4500 11,990,757 03 Nov 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $3,375 +7,500 +0.06% $0.4500 11,998,257 04 Nov 2022 Direct F1, F2
transaction EMMA Common stock, $0.001 par value Purchase $1,750 +5,000 +0.04% $0.3500 12,003,257 28 Nov 2022 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $5,586 +14,700 +0.12% $0.3800 12,017,957 29 Nov 2022 Direct F1, F3
transaction EMMA Common stock, $0.001 par value Purchase $9,389 +22,900 +0.19% $0.4100 12,040,857 30 Nov 2022 Direct F1, F4
holding EMMA Common stock, $0.001 par value 92,794 03 Nov 2022 By Hope International Hospice, Inc. F5
holding EMMA Common stock, $0.001 par value 63,000 03 Nov 2022 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.36 to $0.40, inclusive.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.40 to $0.44, inclusive.
F5 Hope International Hospice, Inc. is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.